The UK’s medical watchdogs will assess data on the jab’s links to rare blood clots in ‘scrupulous detail’ in order to paint a clearer picture on the exact risk-benefit ratio for people in their 30s.
Your most Authoritative news site
The UK’s medical watchdogs will assess data on the jab’s links to rare blood clots in ‘scrupulous detail’ in order to paint a clearer picture on the exact risk-benefit ratio for people in their 30s.